- Home
- CDXS vs NEN Comparison
CDXS vs NEN Comparison
Compare CDXS & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- NEN
- Stock Information
- Founded
- CDXS 2002
- NEN 1977
- Country
- CDXS United States
- NEN United States
- Employees
- CDXS N/A
- NEN N/A
- Industry
- CDXS Major Chemicals
- NEN Building operators
- Sector
- CDXS Industrials
- NEN Real Estate
- Exchange
- CDXS Nasdaq
- NEN Nasdaq
- Market Cap
- CDXS 254.3M
- NEN 262.4M
- IPO Year
- CDXS 2010
- NEN N/A
- Fundamental
- Price
- CDXS $2.69
- NEN $72.49
- Analyst Decision
- CDXS Buy
- NEN
- Analyst Count
- CDXS 2
- NEN 0
- Target Price
- CDXS $11.00
- NEN N/A
- AVG Volume (30 Days)
- CDXS 819.6K
- NEN 450.0
- Earning Date
- CDXS 08-11-2025
- NEN 01-01-0001
- Dividend Yield
- CDXS N/A
- NEN 6.62%
- EPS Growth
- CDXS N/A
- NEN 58.97
- EPS
- CDXS N/A
- NEN 4.56
- Revenue
- CDXS $49,815,000.00
- NEN $82,531,485.00
- Revenue This Year
- CDXS $12.53
- NEN N/A
- Revenue Next Year
- CDXS $22.54
- NEN N/A
- P/E Ratio
- CDXS N/A
- NEN $15.89
- Revenue Growth
- CDXS N/A
- NEN 6.12
- 52 Week Low
- CDXS $1.90
- NEN $68.98
- 52 Week High
- CDXS $6.08
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- CDXS 45.92
- NEN 37.80
- Support Level
- CDXS $2.77
- NEN $72.26
- Resistance Level
- CDXS $3.39
- NEN $73.44
- Average True Range (ATR)
- CDXS 0.19
- NEN 0.16
- MACD
- CDXS -0.06
- NEN -0.01
- Stochastic Oscillator
- CDXS 13.58
- NEN 13.22
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.